Image de couverture de livre

¿ Existe el cáncer localizado de próstata?

Fuente: Redalyc

Enregistré dans:

Détails bibliographiques
Auteur principal:	Bernard LOBEL MANDEL
Format:	Artículo científico
Langue:	es
Publié:	Universidad Peruana Cayetano Heredia 2005
Sujets:	Medicina Prostate cancer localized
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Oncological outcomes of surgery in very high risk pT3b prostate cancer
par: Daimantas Milonas
Publié: (2011)

Comparative antiproliferation of human prostate cancer cells by ethanolic extracts of two groups of Brazilian propolis
par: Cleber Silveira MORAES
Publié: (2010)

Prostate cancer patient’s survival in Lithuania
par: Giedrė Smailytė
Publié: (2012)

Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO.
par: Willisch P, et autres
Publié: (2026)

Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
par: Vladimir Zaichick
Publié: (2020)

Changes in prostate cancer incidence in 50–75-year-old men in Lithuania 2006–2009: effect of early diagnosis program
par: Robertas Adomaitis
Publié: (2011)

Incidence of adenocarcinoma in the transitional zone of the prostate in a public institution. Cochabamba, Bolivia
par: Javier Ferrufino Iriarte
Publié: (2020)

AI-Driven Multi-Targeted Phytochemical Formulation for Prostate Cancer Prevention and Support: A Theoretical Framework for Research
par: Landry, Marie Seshat
Publié: (2025)

The first clinical experience in prostate cancer salvage cryotherapy
par: Ulys Albertas
Publié: (2013)

Cáncer de Próstata. ¿Qué es el antígeno prostático específico?. (La biología del PSA)
par: Juan Fernando Uribe Arcila
Publié: (2007)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
par: Paulius Aliukonis
Publié: (2017)

Molecular analysis of multifocal prostate cancer cases
par: Rasa Sabaliauskaitė
Publié: (2011)

First experience of salvage HDR brachytherapy after prostate cancer radiotherapy
par: Juras Kišonas
Publié: (2014)

Prostate cancer mortality according to marginalization status in Mexican states from 1980 to 2013
par: Luisa E Torres-Sánchez
Publié: (2016)

Dosimetric effectiveness in implants with distinct Ho-166 seed distributions in a prostate model
par: Viviane Vitória Bento Braga
Publié: (2019)

THE MEANING OF TOUCH THE PROSTATE FOR MAN: THE NURSE IN HEALTH PROMOTION
par: Taiane Bertoldi da Costa
Publié: (2013)

Mathematical insights into neuroendocrine transdifferentiation of human prostate cancer cells.
par: Leo Turner
Publié: (2021)

Prostate-specific antigen in men from the municipality of Paipa, Boyacá 2016
par: Angela Liliana Monroy Díaz
Publié: (2018)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
par: Zain Abedali, et autres
Publié: (2024)

Diagnosis and management of neuroendocrine prostate cancer
par: Ivan de Kouchkovsky, et autres
Publié: (2024)

Other‐cause mortality in incidental prostate cancer
par: Francesco Di Bello, et autres
Publié: (2024)

Influence of microbiome in intraprostatic inflammation and prostate cancer
par: Pranav Prakash, et autres
Publié: (2024)

Perfil microbiológico y resistencia antibiótica en las bacteremias postbiopsia transrectal de próstata en el Hospital Universitario Fundación Santa Fé de Bogotá
par: Jorge Eduardo Sejnaui S.
Publié: (2008)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
par: Tianwei Jia, et autres
Publié: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
par: Reyhane Karegar‐Niavol, et autres
Publié: (2024)

Retzius‐sparing versus standard robot‐assisted laparoscopic prostatectomy: A two‐year patient‐reported and oncological assessment
par: Romain Diamand, et autres
Publié: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
par: Eric V. Li, et autres
Publié: (2024)

Prostate cancer focal therapy: surgeon experience influences oncological results
par: Claudio Bovolenta Murta, et autres
Publié: (2024)

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
par: Fabian Falkenbach, et autres
Publié: (2024)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
par: Sean A. Fletcher, et autres
Publié: (2024)

Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
par: Stephen Schmit, et autres
Publié: (2024)

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells
par: Chia‐Ling Hsieh, et autres
Publié: (2024)

Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
par: Shuhei Kamada, et autres
Publié: (2024)

Development and validation of an imageless machine‐learning algorithm for the initial screening of prostate cancer
par: Nicolas Martelin, et autres
Publié: (2024)

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
par: Eli Marie Grindedal, et autres
Publié: (2024)

Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer
par: Julián Córdoba Sánchez, et autres
Publié: (2024)

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
par: Takafumi Yanagisawa, et autres
Publié: (2024)

PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
par: Philip Sutera, et autres
Publié: (2024)

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer
par: Hemal Semwal, et autres
Publié: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
par: Naz Chaudary, et autres
Publié: (2024)